Latest Natera News & Updates

See the latest news and media coverage for Natera. We track all announcements, press releases, and industry mentions in real time, all in one place.

Natera

Molecular diagnostics company specializing in cell-free DNA testing

natera.com

Headquarters: Austin, United States
Founded year: 2004
Company type: Public company
Number of employees: 5,500–10,000
Industry: Biotechnology & Medical Research

Last updated Today

Latest news about Natera

In short: Natera achieved record Q2 2026 revenue growth, received FDA approval for Signatera in bladder cancer, and expanded transplant coverage.

Company announcements

August 6 Natera

Natera reports second quarter 2026 financial results

Total revenues grew 37.7% to $752.8 million, oncology volume rose 57.2%, and the company raised annual revenue guidance.

August 5 Natera

Natera submits Signatera for MIBC companion diagnostic in Japan

Submission follows U.S. FDA approval in MIBC and PMDA approval in colorectal cancer; supported by Phase 3 IMvigor011 data.

July 22 Natera

Natera's Signatera outperformed AMERK in Merkel cell carcinoma study

The JAMA Dermatology publication showed 90% sensitivity vs 55% and a median lead time of 5.1 months.

July 16 Natera

Natera says finalized LCD expands coverage for Prospera portfolio

The new policy increases test frequency for kidney, heart, and lung transplant surveillance, improving upon a July 2025 draft.

Media coverage

Today Traders Union

Natera shares gain more than 4% after record Q2 revenue and raised full-year outlook

Natera surges 4.34% today to $360.32 after record Q2 revenue and bullish guidance, driven by strong oncology growth.

September 8 GuruFocus

NTRA Initiated Coverage by Rothschild & Co -- Price Target Set a

Natera Inc (NTRA) Analyst Rating Update On September 8, 2026, Rothschild & Co initiated coverage on...

September 3 Courthouse News

Natera settles class action over prenatal tests for $8.25M

A class of users claimed the genetic testing company marketed its prenatal tests as highly accurate, despite knowing they could produce false positives that may...

August 27 RTTNews

Natera Partners With Angiex For CtDNA Monitoring In Solid Tumor Trial Using...

Natera, Inc. (NTRA), a clinical genetic testing company announced on Thursday that it will collaborate with privately held Angiex, Inc., to use its Signatera test...

Never miss news about Natera

Track Natera and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Natera competitors & trending companies

Browse news for competitors to Natera and other trending companies.